However, given the reported context-dependent effects of IL-18 in GVHD, along with its emerging promise in immunotherapy, careful examination of its abrogation will be required to balance its proreparative and graft-versus-tumor effects19,59–64. The gene discussed is IL18; the disease is neoplasm.